Overview

Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular Carcinoma

Status:
COMPLETED

Trial end date:
2025-08-30

Target enrollment:

Participant gender:

Summary

To evaluate the effectiveness of the combination of hydrochloride hydromorphone and flurbiprofen ester for post-TACE intravenous patient-controlled intravenous analgesia (PCIA).

Phase:

PHASE4

Details

Lead Sponsor:

First Affiliated Hospital, Sun Yat-Sen University

Collaborators:

Guangzhou Institute of Cancer Reasearch, the Affiliated Cancer Hospital, Guangzhou Medical University
Jinshazhou Hospital of Guangzhou University of Chinese Medicine

Treatments:

flurbiprofen axetil
Hydromorphone